{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "sharesOutstanding": 1468739968, "bookValue": 0.032, "fiftyDayAverage": 0.0228764, "fiftyDayAverageChange": -0.003876401, "fiftyDayAverageChangePercent": -0.16944978, "twoHundredDayAverage": 0.0299407, "twoHundredDayAverageChange": -0.010940701, "twoHundredDayAverageChangePercent": -0.36541232, "marketCap": 27906058, "priceToBook": 0.59374994, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "exchange": "PNK", "shortName": "BIONOMICS LTD", "longName": "Bionomics Limited", "messageBoardId": "finmb_3331473", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.019, "firstTradeDateMilliseconds": 1403616600000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683908812, "regularMarketDayHigh": 0.019, "regularMarketDayRange": "0.019 - 0.019", "regularMarketDayLow": 0.019, "regularMarketVolume": 199500, "regularMarketPreviousClose": 0.019, "fullExchangeName": "Other OTC", "financialCurrency": "AUD", "regularMarketOpen": 0.025, "averageDailyVolume3Month": 44127, "averageDailyVolume10Day": 52295, "fiftyTwoWeekLowChange": 0.009, "fiftyTwoWeekLowChangePercent": 0.9, "fiftyTwoWeekRange": "0.01 - 0.055", "fiftyTwoWeekHighChange": -0.036, "fiftyTwoWeekHighChangePercent": -0.6545454, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "displayName": "Bionomics", "symbol": "BNOEF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Greenhill Road", "city": "Eastwood", "state": "SA", "zip": "5063", "country": "Australia", "phone": "61 8 8150 7400", "website": "https://www.bionomics.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Adrian  Hinton BEC, F.C.A.", "age": 70, "title": "Acting Chief Financial Officer", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 215184, "fmt": "215.18k", "longFmt": "215,184"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Connor  Bernstein M.Sc.", "age": 34, "title": "VP of Strategy & Corp. Devel.", "yearBorn": 1988, "fiscalYear": 2022, "totalPay": {"raw": 229273, "fmt": "229.27k", "longFmt": "229,273"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Spyridon  Papapetropoulos M.D., Ph.D.", "age": 48, "title": "CEO, Pres & Director", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Paul  Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.", "title": "Consultant Chief Medical Officer of Clinical Neuroscience", "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Irwin B.Com., FCIS", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}